Ajay Singh is Founder and CEO of Slayback Pharma. He has led Slayback from its early start-up days to its current position of strength. His career has spanned through various segments of the generic pharmaceutical industry- including the branded side, generics business, biologics as well as the API side. Before Slayback, he was the Vice President of Strategy, Portfolio and Business Development at Dr Reddy’s for the North American Generics Division. In that role, he led product strategy, business development, key M&A initiatives, settlement of patent litigations, and the pursuit towards complex generic opportunities through internal and external R&D alliances. Ajay has an MBA from IIM Bangalore and an LLB from Delhi University.